Table 1 Data sources consulted to complete the reporting template and scope of the reporting systems
Country | National shortage reporting system | Reporter | Drugs included in reporting system | National drug formulary for hospitals or community pharmacy consulted to complete reporting template |
|---|---|---|---|---|
Belgium | Federal Agency for Medicines and Health Products (FAGG) | Marketing authorization holders | Drug for which unavailability cause a risk for public health and have no therapeutic alternative | Belgian Centre for Pharmacotherapeutic Information (BCFI) |
Farmaco-contingentering.be | Pharmacists | Products subjected to supply quota | Â | |
The Netherlands | Farmanco.nl | Marketing authorization holders, wholesalers, pharmacists | Unlimited | Geneesmiddelenrepertorium.nl |
England | Pharmaceutical Services Negotiation Committee (PSNC) | Pharmacists | Products for community pharmacy only | Eudrapharm |
Italy | Italian Medicines Agency (AIFA) | Marketing authorization holders, health care providers, health departments, patients or associations | Unlimited | Italian Drug Formulary (AIFA) |
Eudrapharm | ||||
Germany | Federal Institute for Drugs and Medical Devices (Bfarm) | Marketing authorization holders | Products for treatment of threatening or serious diseases for which no alternatives are available | Federal Institute for Drugs and Medical Devices (Bfarm) |
Eudrapharm | ||||
Spain | Spanish Agency for Medicines and Health Products (aemps) | Marketing authorization holders or health authorities of autonomous communities | Unlimited | Spanish Agency for Medicines and Health Products (aemps) |
France | National Agency for Safety of Drugs and Health Products (ansm) | Pharmacists and hospitals | Drug for which unavailability cause a risk for public health and have no therapeutic alternative | National Agency for Safety of Drugs and Health Products (ansm) |